Hypercholesterolemia, Familial
Metabolic·MeSH: Hyperlipoproteinemia Type II
Prevalence
0.5 / 100K
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| isis 301012 | TG THERAPEUTICS, INC. (TGTX) |
Frequently asked questions
How many drugs are in development for Hypercholesterolemia, Familial?
BioSniper tracks 1 drug in development for Hypercholesterolemia, Familial across 1 company.
How many clinical trials target Hypercholesterolemia, Familial?
There are 3 clinical trials targeting Hypercholesterolemia, Familial tracked by BioSniper.
What is the prevalence of Hypercholesterolemia, Familial?
The estimated prevalence of Hypercholesterolemia, Familial is approximately 0.5 per 100,000 population.
Deep-dive into Hypercholesterolemia, Familial
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis